Evidence map›Paper›PMID 29374195›Full record

ArticleScientific reports2018

Restrained management of copper level enhances the antineoplastic activity of imatinib in vitro and in vivo.

Iftekhar Hassan, Azmat Ali Khan, Shazia Aman, Wajhul Qamar, Hossam Ebaid, Jameel Al-Tamimi, Ibrahim M Alhazza, Ahmed M Rady

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Cytotoxic Activity of Antineoplastic Agents on Fertility: A Systematic Review.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2020
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. The Alleviative Effect of Vitamin BBioMed research international · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Iftekhar HassanDepartment of Zoology, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia. iftekharhassan2002@gmail.com.
Azmat Ali KhanPharmaceutical Biotechnology Laboratory, Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.
Shazia AmanDepartment of Biochemistry, J N Medical College and Hospital, Aligarh Muslim University, Aligarh, India.
Wajhul QamarBiological Unit, Central Laboratory, Research Center, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.
Hossam EbaidDepartment of Zoology, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.
Jameel Al-TamimiDepartment of Zoology, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.
Ibrahim M AlhazzaDepartment of Zoology, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.
Ahmed M RadyDepartment of Zoology, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.
King Saud University · SAAligarh Muslim University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study was designed to investigate if elevated copper level can be targeted to enhance the efficacy of a significant anticancer drug, imatinib (ITB). The antineoplastic activity of this drug was assessed in the HepG2, HEK-293, MCF-7 and MDA-MD-231 cells targeting elevated copper level as their common drug target. The cell lines were treated with the different doses of copper chloride (Cu II) and disulfiram (DSF) alone as well as in their combinations with the drug for 24 h in standard culture medium and conditions. The treated cells were subjected to various assays including MTT, PARP, p-53, caspase-7, caspase-3, LDH and single cell electrophoresis. The study shows that DSF and Cu (II) synergizes the anticancer activity of ITB to a significant extent in a dose-specific way as evidenced by the combinations treated groups. Furthermore, the same treatment strategy was employed in cancer-induced rats in which the combinations of ITB-DSF and ITB-Cu II showed enhanced antineoplastic activity as compared to ITB alone. However, DSF was more effective than Cu (II) as an adjuvant to the drug. Hence, restrained manipulation of copper level in tumor cells can orchestrate the redox and molecular dispositions inside the cells favoring the induction of apoptosis.

Indexed as

Drug SynergismAnimalsAntineoplastic AgentsCell SurvivalChemotherapy, AdjuvantCopperDisulfiramImatinib MesylateMetabolismNeoplasms, ExperimentalRatsTreatment OutcomeAntineoplastic AgentsCoppercupric chlorideDisulfiramImatinib Mesylate

Identifiers

PMID29374195
PMCPMC5786010
OpenAlexW2804247948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.